Stock Earnings

Question 1

Quels sont les états financiers clés de Intellia Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Intellia Therapeutics Inc a un total d'actifs de $1,191, un bénéfice net loss de $-519

Question 2

Quels sont les ratios financiers clés pour NTLA ?

Accepted Answer

Le ratio de liquidité de Intellia Therapeutics Inc est 3.73, la marge nette est -910.52, les ventes par action sont de $0.57.

Question 3

Comment les revenus de Intellia Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Intellia Therapeutics Inc largest revenue segment is Genome Editing-based Therapies, at a revenue of 57,877,000 in the most earnings release.For geography, United States is the primary market for Intellia Therapeutics Inc, at a revenue of 57,877,000.

Question 4

Intellia Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Intellia Therapeutics Inc a un bénéfice net loss de $-519

Question 5

Intellia Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Intellia Therapeutics Inc a un passif de 319

Question 6

Combien d'actions en circulation Intellia Therapeutics Inc a-t-elle ?

Accepted Answer

Intellia Therapeutics Inc a un total d'actions en circulation de 102.02

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	57	57	36	52	33	57
Revenue Growth (YoY)	-30%	57.99%	-31%	57.99%	-42%	33%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	119	125	116	90	71	44
Research & Development	417	466	435	419	229	150
Operating Expenses	536	592	551	510	300	194
Other Non Operating Income (Expenses)	--	0	0	-13	--	--
Pretax Income	-445	-519	-481	-474	-267	-134
Income Tax Expense	--	--	--	--	--	--
Net Income	-445	-519	-481	-474	-267	-134
Net Income Growth	-49%	8%	1%	78%	99%	35%
Shares Outstanding (Diluted)	110.18	98.84	88.77	76.97	70.89	55.99
Shares Change (YoY)	9%	11%	15%	9%	27%	19%
EPS (Diluted)	-4.04	-5.25	-5.42	-6.16	-3.78	-2.4
EPS Growth	-53%	-3%	-12%	63%	57.99%	14%
Free Cash Flow	-412	-354	-408	-346	-237	-53
Free Cash Flow Per Share	-3.73	-3.58	-4.59	-4.49	-3.34	-0.94
Gross Margin	--	--	--	--	--	--
Operating Margin	-838.59%	-936.84%	-1,430.55%	-880.76%	-809.09%	-238.59%
Profit Margin	-780.7%	-910.52%	-1,336.11%	-911.53%	-809.09%	-235.08%
Free Cash Flow Margin	-722.8%	-621.05%	-1,133.33%	-665.38%	-718.18%	-92.98%
EBITDA	-466	-524	-507	-451	-261	-130
EBITDA Margin	-817.54%	-919.29%	-1,408.33%	-867.3%	-790.9%	-228.07%
D&A For EBITDA	12	10	8	7	6	6
EBIT	-478	-534	-515	-458	-267	-136
EBIT Margin	-838.59%	-936.84%	-1,430.55%	-880.76%	-809.09%	-238.59%
Effective Tax Rate	--	--	--	--	--	--

Intellia Therapeutics Inc (NTLA) Price

NTLA Stock Price Chart

NTLA Income

Follow-Up Questions